文献速递细菌感染、耐药与抗菌药物

低收入地区抗生素使用分析模型

A model for analysis of antibiotic usage in low-income settings.
PubMed 文献 · J Antimicrob Chemother · 2023-01-01

该研究在无电子健康记录的三级医院普通外科病房,回顾性利用病房登记和住院药品记录计算一个日历年内抗生素的每百患者日DDD(DDDs/100 PDs)及费用,并按Access、Watch、Reserve分类。结果显示静脉用复方阿莫西林克拉维酸、头孢呋辛和甲硝唑年使用量显著高于其他抗生素,部分病房存在异常使用;静脉剂型复方阿莫西林克拉维酸(5倍)、甲硝唑(3倍)和环丙沙星(2倍)使用量超过口服剂型。基于AWaRe分类的抗生素使用比例在病房间无显著差异。

要点

  • 静脉用复方阿莫西林克拉维酸、头孢呋辛和甲硝唑年使用量显著高于其他抗生素。
  • 静脉剂型复方阿莫西林克拉维酸、甲硝唑和环丙沙星使用量分别为口服剂型的5倍、3倍和2倍。
  • 静脉用克林霉素和美罗培南合计占抗生素支出的43.8%。

核心结论

  • 该研究展示了机构内年度抗生素使用及相关费用的差异。
  • DDD/100 PDs指标及所用方法适用于机构内和机构间抗生素使用分析,尤其适用于低收入地区。

研究设计与样本

  • 回顾性研究,从三级医院普通外科病房的病房登记和住院药品记录计算一个日历年内抗生素的DDDs/100 PDs。
  • 抗生素按Access、Watch、Reserve分类,年度抗生素支出根据州药品采购者价目表估算。

主要发现

  • 静脉用复方阿莫西林克拉维酸、头孢呋辛和甲硝唑的年使用量显著高于其他抗生素,且某些病房对相同抗生素表现出异常使用。
  • 静脉剂型复方阿莫西林克拉维酸(5倍)、甲硝唑(3倍)和环丙沙星(2倍)的使用量超过口服剂型。
  • 基于AWaRe分类的抗生素使用比例在病房间无显著差异。
  • 两个病房的年度每百患者日支出为异常值。
  • 静脉用克林霉素和美罗培南合计占抗生素支出的43.8%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Quantification of antibiotic usage is an important component of antimicrobial stewardship programmes. We aimed to estimate institutional antibiotic usage and costs using methodology and metrics applicable to low-income settings without electronic health records. METHODS: The DDD per 100 patient-days (DDDs/100 PDs) of antibiotics used in a calendar year was calculated retrospectively from ward registers and inpatient drug records in general surgical wards of a tertiary hospital. The antibiotics were categorized using the Access, Watch, Reserve classification. The annual expenditure on antibiotics was estimated from price lists of the state medication procurer. RESULTS: Annual usage of IV co-amoxiclav, cefuroxime and metronidazole was significantly higher than other antibiotics and certain wards showed outlier use of the same. The IV formulations of co-amoxiclav (5-fold), metronidazole (3-fold) and ciprofloxacin (2-fold) were used in excess of the oral formulation. Proportionate antibiotic usage based on the AWaRe category did not vary significantly between wards. Two wards were outliers for annual expenditure/100 PDs. IV clindamycin and meropenem combined accounted for 43.8% of expenditure on antibiotics. CONCLUSIONS: This study demonstrated intra-institutional variations of annual antibiotic usage and related costs. The metric DDD/100 PDs and the methodology used here are suitable for intra- and inter-institutional analyses of antibiotic usage, particularly in low-income settings.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Rockwood N, Mani U, Ranawaka S, et al. A model for analysis of antibiotic usage in low-income settings. J Antimicrob Chemother. 2023. PMID: 37352113. doi:10.1093/jac/dkad199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。